Johnson & Johnson (JNJ) Cash from Financing Activities (2016 - 2025)
Johnson & Johnson's Cash from Financing Activities history spans 17 years, with the latest figure at -$1.4 billion for Q4 2025.
- For Q4 2025, Cash from Financing Activities fell 2.16% year-over-year to -$1.4 billion; the TTM value through Dec 2025 reached -$5.5 billion, down 76.85%, while the annual FY2025 figure was -$5.5 billion, 76.85% down from the prior year.
- Cash from Financing Activities for Q4 2025 was -$1.4 billion at Johnson & Johnson, up from -$8.9 billion in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $10.4 billion in Q1 2025 and bottomed at -$11.3 billion in Q4 2023.
- The 5-year median for Cash from Financing Activities is -$3.8 billion (2021), against an average of -$2.4 billion.
- The largest annual shift saw Cash from Financing Activities crashed 818.49% in 2021 before it soared 1808.79% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$2.2 billion in 2021, then crashed by 98.69% to -$4.4 billion in 2022, then decreased by 6.16% to -$4.7 billion in 2023, then skyrocketed by 71.21% to -$1.3 billion in 2024, then dropped by 2.16% to -$1.4 billion in 2025.
- Per Business Quant, the three most recent readings for JNJ's Cash from Financing Activities are -$1.4 billion (Q4 2025), -$8.9 billion (Q3 2025), and -$5.7 billion (Q2 2025).